Smith Asset Management Group »

Supernus Pharmaceuticals shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2021-06-30 $22k 700 31.43
2021-03-31 $18k 700 25.71
2020-12-31 $807k 32k 25.17
2020-09-30 $788k 38k 20.85
2020-06-30 $898k 38k 23.75
2019-09-30 $429k 16k 27.45
2019-06-30 $530k 16k 33.07
2019-03-31 $573k 16k 35.01
2018-12-31 $551k 17k 33.24
2018-09-30 $835k 17k 50.36
2018-06-30 $3.6M 60k 59.84
2018-03-31 $2.6M 58k 45.80
2017-12-31 $1.8M 46k 39.86
2017-09-30 $2.5M 61k 40.01
2017-06-30 $3.1M 72k 43.10
2017-03-31 $4.0M 129k 31.30
2016-12-31 $3.3M 132k 25.25
2016-09-30 $4.5M 183k 24.73
2016-06-30 $4.1M 204k 20.37
2016-03-31 $3.6M 234k 15.25
2015-12-31 $16k 1.2k 13.20